Research
Education
Solutions
Sign In
EN
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Nanomedicine Research Center,
Department of Neurosurgery,
Nanomedicine Research Center, Department of Neurosurgery
Rameshwar Patil has not added Biography.
If you are Rameshwar Patil and would like to personalize this page please email our Author Liaison for assistance.
Side-chain modified analogues of histaprodifen: asymmetric synthesis and histamine H1-receptor activity.
Bioorganic & medicinal chemistry letters Feb, 2006 | Pubmed ID: 16266803
Brain tumor tandem targeting using a combination of monoclonal antibodies attached to biopoly(beta-L-malic acid).
Journal of controlled release : official journal of the Controlled Release Society Oct, 2007 | Pubmed ID: 17630012
Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: what should be the policy?
NeuroImage Jan, 2011 | Pubmed ID: 20149882
Temozolomide delivery to tumor cells by a multifunctional nano vehicle based on poly(β-L-malic acid).
Pharmaceutical research Nov, 2010 | Pubmed ID: 20387095
Phosphodiesterase type 5 inhibitors increase Herceptin transport and treatment efficacy in mouse metastatic brain tumor models.
PloS one , 2010 | Pubmed ID: 20419092
Inhibition of brain tumor growth by intravenous poly (β-L-malic acid) nanobioconjugate with pH-dependent drug release [corrected].
Proceedings of the National Academy of Sciences of the United States of America Oct, 2010 | Pubmed ID: 20921419
Polymalic acid-based nanobiopolymer provides efficient systemic breast cancer treatment by inhibiting both HER2/neu receptor synthesis and activity.
Cancer research Feb, 2011 | Pubmed ID: 21303974
The optimization of polymalic acid peptide copolymers for endosomolytic drug delivery.
Biomaterials Aug, 2011 | Pubmed ID: 21514661
Poly(methyl malate) nanoparticles: formation, degradation, and encapsulation of anticancer drugs.
Macromolecular bioscience Oct, 2011 | Pubmed ID: 21793213
Nanobiopolymer for direct targeting and inhibition of EGFR expression in triple negative breast cancer.
PloS one , 2012 | Pubmed ID: 22355336
Nanoconjugate Platforms Development Based in Poly(β,L-Malic Acid) Methyl Esters for Tumor Drug Delivery.
Journal of nanotechnology , 2010 | Pubmed ID: 23024655
Distinct mechanisms of membrane permeation induced by two polymalic acid copolymers.
Biomaterials Jan, 2013 | Pubmed ID: 23063368
Cellular Delivery of Doxorubicin via pH-Controlled Hydrazone Linkage Using Multifunctional Nano Vehicle Based on Poly(β-L-Malic Acid).
International journal of molecular sciences , 2012 | Pubmed ID: 23109877
Toxicity and efficacy evaluation of multiple targeted polymalic acid conjugates for triple-negative breast cancer treatment.
Journal of drug targeting Dec, 2013 | Pubmed ID: 24032759
Cedars-Sinai Medical Center
Julia Y. Ljubimova1,
Hui Ding1,
Jose Portilla-Arias1,
Rameshwar Patil1,
Pallavi R. Gangalum1,
Alexandra Chesnokova1,
Satoshi Inoue1,
Arthur Rekechenetskiy1,
Tala Nassoura1,
Keith L. Black1,
Eggehard Holler1
1Nanomedicine Research Center, Department of Neurosurgery, Cedars-Sinai Medical Center
Privacy
Terms of Use
Policies
Contact Us
Recommend to library
JoVE NEWSLETTERS
JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archive
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Faculty Resource Center
Authors
Librarians
Access
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved